Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 14 studies | 38% ± 17% | |
lung | 10 studies | 25% ± 8% | |
intestine | 5 studies | 21% ± 6% | |
peripheral blood | 4 studies | 28% ± 10% | |
eye | 4 studies | 38% ± 16% | |
liver | 4 studies | 35% ± 18% | |
adipose | 4 studies | 22% ± 3% | |
kidney | 3 studies | 25% ± 3% | |
heart | 3 studies | 19% ± 4% | |
bone marrow | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5579.03 | 1445 / 1445 | 100% | 65.79 | 183 / 183 |
intestine | 100% | 6419.43 | 966 / 966 | 100% | 77.87 | 527 / 527 |
ovary | 100% | 5051.67 | 180 / 180 | 100% | 69.30 | 430 / 430 |
prostate | 100% | 5602.28 | 245 / 245 | 100% | 86.03 | 502 / 502 |
breast | 100% | 5150.04 | 459 / 459 | 100% | 94.02 | 1115 / 1118 |
stomach | 100% | 4057.91 | 359 / 359 | 100% | 74.82 | 285 / 286 |
bladder | 100% | 6899.86 | 21 / 21 | 100% | 74.43 | 502 / 504 |
lung | 100% | 4285.74 | 577 / 578 | 100% | 59.90 | 1152 / 1155 |
uterus | 100% | 4817.28 | 170 / 170 | 99% | 67.07 | 455 / 459 |
thymus | 100% | 4729.78 | 653 / 653 | 99% | 51.78 | 598 / 605 |
skin | 100% | 7725.86 | 1809 / 1809 | 99% | 81.26 | 466 / 472 |
brain | 100% | 2598.27 | 2635 / 2642 | 99% | 43.86 | 696 / 705 |
pancreas | 100% | 3568.24 | 327 / 328 | 98% | 45.42 | 175 / 178 |
kidney | 100% | 3988.64 | 89 / 89 | 92% | 31.75 | 830 / 901 |
liver | 100% | 2095.41 | 225 / 226 | 83% | 23.89 | 339 / 406 |
adrenal gland | 100% | 2557.88 | 258 / 258 | 69% | 14.40 | 159 / 230 |
adipose | 100% | 4032.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5079.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 52.60 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 68.08 | 29 / 29 |
spleen | 100% | 4440.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 66.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.12 | 1 / 1 |
muscle | 100% | 3681.68 | 799 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 5012.02 | 866 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 1905.91 | 797 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030071 | Biological process | regulation of mitotic metaphase/anaphase transition |
GO_0032435 | Biological process | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0045582 | Biological process | positive regulation of T cell differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0045663 | Biological process | positive regulation of myoblast differentiation |
GO_0030850 | Biological process | prostate gland development |
GO_0006338 | Biological process | chromatin remodeling |
GO_0070316 | Biological process | regulation of G0 to G1 transition |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_2000819 | Biological process | regulation of nucleotide-excision repair |
GO_0045596 | Biological process | negative regulation of cell differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006337 | Biological process | nucleosome disassembly |
GO_2000781 | Biological process | positive regulation of double-strand break repair |
GO_0007399 | Biological process | nervous system development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0140288 | Cellular component | GBAF complex |
GO_0071565 | Cellular component | nBAF complex |
GO_0071564 | Cellular component | npBAF complex |
GO_0000776 | Cellular component | kinetochore |
GO_0032991 | Cellular component | protein-containing complex |
GO_0016514 | Cellular component | SWI/SNF complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001741 | Cellular component | XY body |
GO_0016363 | Cellular component | nuclear matrix |
GO_0016586 | Cellular component | RSC-type complex |
GO_0035060 | Cellular component | brahma complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0001673 | Cellular component | male germ cell nucleus |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0042393 | Molecular function | histone binding |
GO_0031492 | Molecular function | nucleosomal DNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SMARCC1 |
Protein name | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 protein |
Synonyms | BAF155 |
Description | FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. May stimulate the ATPase activity of the catalytic subunit of the complex . Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). . |
Accessions | Q05BW5 Q58EY4 ENST00000454240.1 ENST00000254480.10 Q92922 Q05CR1 F8WE13 |